Skip to content

Defect in human NK cells, HPV infection and development of cancer

Immunogenetics of Natural Killer cell receptors in HPV infected women with or without cervical cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/09/009621
Enrollment
500
Registered
2017-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cervical cancer cases,HPV infected women with healthy cervix

Interventions

None listed

Sponsors

ICMR National Institute for Research in Reproductive Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Study subjects (from TMH): Group I.Women with established cervical cancer Control subjects (from KEM Hospital): Group II. HPV infected women having normal cervix (PV examination and Pap smear results) Group III. Women without any genital infection and having normal cervix (PV examination and Pap smear results)

Exclusion criteria

Exclusion criteria: Women with any other cancer will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
The study will highlight, why NK cells fail to recognize the tumor cells that become cancerous. Timepoint: Study period 3 years

Secondary

MeasureTime frame
Comparing the polymorphisms/expression seen in NK cell receptors may highlight, which genes/genotypes or polymorphisms are associated with susceptibility to HPV infection, persistent infection and further with development of cervical cancer. In future, identification of such susceptible or protective host factors/genes may be useful for the benefit of the case management.Timepoint: Study period 3 years

Countries

India

Contacts

Public ContactDr Jayanti Mania Pramanik

ICMR National Institute for Research in Reproductive Health

pramanikj@nirrh.res.in022-24192039

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026